Member Info for Trickymatters

I am a democratic socialist and an ethical investor. I have tried my heart out to flag up the life changing opportunity looking us in the face. From Monday a lot of the damaging slurs we have had to endure which has caused some confusion in the wider market and slowed our progress, will be put to bed decisively. Professor Moore:10. John Deeks: 0. Lateral flow tests 98% sensitivity. On Monday morning the derampers will give it one last go. If anyone falls for it and the price drops by one penny I am going to be up at 8am ready to buy more shares. I have firepower. I won't be alone. It is most unlikely anyone will get in any lower later on. This is the time. GLA.

Superb. Well done all ODX holders. Time to stop sitting on the sidelines for those who still hesitating. I expect more coverage in the Sunday papers. ODX will be selling every single test they make before they have made it. The Good Law Project win puts more pressure on for transparency. My guess is we will see the detail of the ODX contract sooner rather than later. Manufacturing for Mologic and/or Avacta tests depending on results. Preferred supplier with GAD for the best tests. Mass testing to support the exit from lockdown. The Lancet have confirmed that the ABC19 test is just as good as the first independent assessment led by Ulster university's Professor Tara Moore. She is absolutely vindicated.
ODX are manufacturing both antigen and antibody tests.
There is nothing left for derampers.
Exit plan scheduled for Monday. Looking forward to seeing a lot more of ODX across all forms of media. Market cap will soon reflect x 2.5 projected earnings.

Hawkes bay, yep. I am a woman. Are you some sort of super sleuth then putting 2 and 2 together like that ;)
Alright Decolady!
Yeah I am late for a ladies who usually lunch but are now obliged to settle for a walk. So I will contemplate thigh deep this weekend. GLA.

Mike Edwards on Twitter just shared a video with the NHS logo on to explain how to take a lateral flow test which says Public Health England and other independent studies say that they successfully spot 98% of people who are at an infectious stage of the virus! Definitely have to go now. See you on Monday!

I haven't got any balls. But I am thinking of going in a bit deeper. Knee deep atm. You guys banging on about sellers all day makes me think I should wait before ruining my lovely low average. I know this will fly though. Decisions, decisions hey?

Hasn't dropped at all. Jesus. We have all got the data right in front of us. Who are these people that suddenly appear? Nose in trough?! I do despair about sorry people. Going out for the day. Looking forward to Monday. GLA.

Harry and Meghan have managed to knock lateral flow tests off the news for the first time in a couple of days. But the narrative is still stuck in the idea that lfts aren't very accurate. That will change on Monday when we will hear the exit plan and there should be clear explanation that next generation lfts are 98% sensitive. The pill was only 99% accurate till recently. Then the market will wake up to the opportunity for ODX. Preferred supplier of antigen and antibody tests. 100 million capacity and 5.7 billion budget set aside for tests and mostly but not all for lfts. Of course we move on news. Last April this share was 30p. I bought in at 33p on the news that the RTC was set up after a day or twos hesitancy. No-one knew that these share options needed cashing in or they would be lost so we lost momentum this week. Let's put that to bed now. Read the tweet from ODX's rules and regulations that Bushmaster took time to find and share if you want reassurance. Let's try to get this board looking a bit more positive before Monday. We have a good week ahead. We should make the best of it whatever our plans and investment strategies may be.

Mikodox is hilarious. He's in and out of everything in a week and never makes any money as a consequence! Lol.

They have no argument left now. When there was ambiguity about immunity and some of us were sharing the latest research they tried to exploit the confusion. Deeks. Ditto. We laughed at Deeks stats. Within weeks the great and the good laughed at his stats and eventually Sir John Bell wrote to the papers with the chairwoman of the MHRA to call him out for spreading dangerous 'misinformation '.
Now they have nothing left they don't trust the CEO, the government plans that have been specified to the House of Commons select committee. £5.7 billion left in the budget. A £1 billion contract for antigen lfts. At least £100 million contracts for antibody tests. On bidstats. In the papers. Monday all will be revealed. Not long to go now. GLA.

I'm in GDR at 56p. Wolf was deramping away at £1.45. Then he bought in. The patience of a gnat. Sigh. Poor Wolf.

Ihavenoclue, keep your hair on mate. Yesterday's RNS: 'This shipment allows us to start initial sales activity and prepare the market for wider commercial roll out'. So it's a little bit of a work in progress.
Blimey. I think the derampers are getting to you. I don't deramp my own investments. Responding to perfectly reasonable worries raised about a slight dissonance between the two RNS'. I think we will have another update soon. All good.

I have just been listening to a program about the end of lockdown on radio 4. A lot of it was about lfts. Something that has really struck me in recent times is that the narrative about lfts is basically stuck on the narrative about Innova tests and their limitations. Not for the first time Cv19 shareholders are ahead of the curve in understanding these issues. We are all fully aware that we are going to be getting very sensitive, accurate lfts going forward. It won't be a question of take a test and maybe don't assume it means anything because it's only 86% sensitive. It will be take a test and you either have the virus or you don't. Or take a test and you have immunity or you don't. Even the academics who get invited to media interviews (unless it's the top tier who have been involved in evaluation of tests) are behind the curve. It won't be long before the narrative shifts definitively. From Monday actually. Once this is firmly and widely appreciated, ODX being in the place we are as a preferred supplier for both types of lft especially antigen, will become a very attractive longer term investment prospect. I really hope the tone of this board starts to improve tomorrow. We need to look like the intelligent people we are. We need to stay confident and positive. I think it's good that the trolls are only talking to themselves now. I know it's hard. I find it hard. But this is a brilliant company on the cusp of transformational news. So if every real investor steps in whenever you can for genuine discussions, sharing research or sharing expectations or just having a laugh and being visible it will totally raise the tone. If the ratio is 3 to 1 of trolls and derampers vs us it's going to slow us down. People do read the board. I read it- not to rely on it but to get a sense of sentiment. On Aim especially, sentiment drives confidence drives high volume investment. Which is how we build a better share price. It doesn't matter as much on the main markets because they are covered routinely by the media.

Won't happen inside 2 weeks. A bit over ambitious if anyone thought they would be firing on all cylinders that fast. Before I became a pi I worked as a management consultant for an SME. We won a very big 2 year government contract in 2008 and we set up a consortium with 4 other small firms so we had the capacity to deliver. It took us a couple of months to train everyone to try to ensure the same standards of work and get a delivery plan and procedures set up. This partnership is highly experienced in their core skills and they know their products. But they have to explain it to people who may be new to it. Then there's the logistics of getting all those machines out and set up in multiple locations. They will do it faster than we did because the nature of the work is clear cut and they already have systems and experienced teams ready. But they need to sleep sometimes hey. I think we will get a much more substantial update before long.
Then we will get those huge volumes of trades back that we saw here very recently with some new iis buying in and we're cooking with gas.

Revised target from 1.50 to £2.62. Not much talk about our fabulous fundamentals though. All a bit charty farty woo woo for my liking. This will easily do £2.70 once sales start being reported. I think they will do a trading update soon to let us know that they have started and to qualify the distribution network.

And JAdam is over on the NCYT board predicting a fall to £5.50. Oh dear. Derampers are getting very excited everywhere today and tomorrow they will be conspicuously absent.

Their sp has gone up. Hey ho.

They have just appointed a new chair. Check the ODX site for yourself. Under governance. So not sacked. Just demoted.

Looks like the regs have changed from £250k in 2017 to £120K maximum market value now for Dec 2020 when this article was published. Rest of the article is here.
Qualifying companies
The requirements that companies have to meet for options to qualify under EMI are similar to the requirements for the Enterprise Investment Scheme, the Corporate Venturing Scheme and Venture Capital Trusts. However, both quoted and unquoted companies can qualify for EMI.
In summary, the company must:
• be independent (and not be controlled by another company)
• have only qualifying subsidiaries (including qualifying property managing subsidiaries after 17 March 2004)
• trade in the UK (more than 50% of sales must come from the UK)
• have gross assets valued under £30 million (this is measured at the time the option is granted and applies to the consolidated assets of the group where there is more than a single company)
• employ fewer than 250 people (at the date of grant)
• not undertake certain excluded activities (including dealing in shares, property development, provision of legal or accountancy services, shipbuilding, coal and steel production)
Independence
A company whose shares are subject to EMI options must be independent, that is, not being a 51% subsidiary (more than 50% of its ordinary share capital owned by another company), or controlled by another company (or another company and persons connected with it).

https://www.netlawman.co.uk/ia/share-schemes-introduction#:~:text=A%20company%20whose%20shares%20are%20subject%20to%20EMI,(or%20another%20company%20and%20persons%20connected%20with%20it).
'They are designed to help small, higher risk companies recruit and retain employees who have the skills to help them grow and succeed. They are also a way of rewarding employees for taking a risk by investing their time and skills to help small companies achieve their potential.
The main piece of legislation that is applicable is Schedule 5 of the Income Tax (Earnings and Pensions) Act 2003 (abbreviated to ITEPA 2003), but it is by no means the only piece of law that you need to consider.
An EMI scheme as a tax-advantaged reward scheme
EMI share schemes are popular because they are tax efficient (or "tax advantageous") for both the company and the employees.
The grant of the option is tax-free. Normally there is no income tax or National Insurance contributions (NICs) for the employee to pay when the option is exercised.
Nor are there normally any employer NICs to pay.
If the shares are sold at a gain, any capital gains tax (CGT) charge may be reduced because taper relief starts from the date that the option is granted.

Requirements for a scheme to qualify as an EMI scheme
In order for the share option scheme to qualify as an EMI scheme, certain requirements must be met. These are as follows, and expanded on in the rest of this article.
• the scheme has been notified to HMRC within 92 days of the grant
• the employee is eligible
• the terms of the option qualify
• the type of share under option qualifies
• the company whose shares are under option is a qualifying company
Qualifications for the employee
For an employee to be eligible for the scheme, he or she must:
• work for the company, or one of its group companies for at least 25 hours per week, or, if less, for 75% of his or her working time per week
• not own more than 30% of the ordinary share capital of the company
Eligibility is discussed in greater detail here.
Terms of the option
More information about the terms of the option agreement can be found here. Two important ones relate to purpose and maximum entitlement.
Purpose
The options must be granted for commercial reasons to recruit or retain employees in a company, and not as part of an arrangement one of the main purposes of which is to avoid tax.
Maximum entitlement
An employee may not hold unexercised qualifying EMI options that have a market value of more than £120,000.
If an option granted to an employee causes the £120,000 limit to be exceeded, the excess will not qualify as an EMI option.
The market value of any shares for this purpose is the price they might reasonably be expected to fetch on the open market, free from any restrictions or risk of forfeiture to which they may be subject. To Be Continued.

I'll share the link about EMI shares today when I'm on my PC. I've looked at 3 different legal briefings on the matter last week. Or you can look it up.